RESEARCH REPORT
The State of Patient Access 2025
MMIT and The Dedham Group surveyed 250 pharma and biotech leaders on how payer restrictions are reshaping launch strategy.
INFOGRAPHIC
Start Targeting With Greater Precision with NorstellaLinQ
Learn about NorstellaLinQ, your all-in-one, fully linked, clinically-validated real-world data ecosystem.
NEW PRODUCT
Patient Data for Faster, Smarter Market Access Decisions
BIN/PCN/Group data offers a more accurate way forward, with standardized identifiers that deliver consistent, trusted results.
USE CASE
ReimbursementCodes APIs Speed Claim Review and Reduce Overpayments
In this use case, learn how one plan saved at least $250K each year by moving to an automated, scalable claims review process.
